Albert Kwok

Co-founder and CSO @Nuntius Therapeutics

London, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2021 — Present

Co-founder and CSO @Nuntius Therapeutics

View department →

London, GB

At Nuntius Therapeutics (a VC-backed biotech), we set out to build a new generation of tissue-targeted mRNA medicines by combining AI with advanced nanomedicine. Our mission is to solve one of the core bottlenecks for RNA therapeutics - precise, systemic delivery to the right cells - by creating an AI-driven, tissue-targeted mRNA delivery platform and and advancing a focused pipeline of mRNA therapies in oncology, lung diseases, and neurodegenerative diseases.

EDUCATION

2005 — 2009

UCL

PhD, Molecular Medicine

2004 — 2005

UCL

Master's degree, Biomedicine

2001 — 2004

The University of Hong Kong

Bachelor of Science - BS, Biotechnology

2021 — 2021

Y Combinator

Nuntius Therapeutics / W21

SKILLS

Molecular CloningScienceBiochemistryProtein ExpressionGeneticsLife SciencesFlow CytometryCellPcrMolecular BiologyFluorescence MicroscopyCancerCell BiologyCell CultureBiotechnologyDnaTransfection

ABOUT ALBERT KWOK

Scientist-founder & healthcare investor | 20+ years’ experience across gene & cell therapy, vaccines, oncology, immunology, neurology, rare & cardiometabolic diseases

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Albert Kwok — Co-founder and CSO at Nuntius Therapeutics in London, GB | Unifers